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Abstract- Improving patient self-management can have a 
greater impact than improving any clinical treatment (WHO). 
We propose here a systematic and comprehensive user centered 
design approach for delivering a technological platform for 
diabetes disease management.  The system was developed under 
the METABO research project framework, involving patients 
from 3 different clinical centers in Parma, Modena and Madrid. 
 
I.    INTRODUCTION 
ncorporating information technology in chronic disease 
management with a positive impact is an issue that still 
requires research efforts and investments. Health 
Information Systems (HIS) usually provide support related to 
guidelines, patient condition, and reminders to caregivers but 
this is not enough. 
In 2007, Dorr et al. performed a systematic review of 
literature evaluating, from 1996-2005 (109 papers reviewed), 
informatics systems used in chronic disease management [1]:  
results of the literature analysis suggested that treatment 
adherence was positive, a decision support system was 
helpful in providing prompts but it was not helpful if it only 
focused on providing access to guidelines. Guidelines 
adherence was the most evaluated process with 79% of 
positive results. A large amount of studies came up with 
usability recommendations but a formal usability approach 
was adopted few times: we thus propose a systematic and 
comprehensive user centered design approach for delivering a 
technological platform for diabetes disease management.  
 
II.    MATERIALS AND METHODS 
The aim of User Centered Design methodology is to satisfy 
the needs, the expectations and the satisfaction of the final 
users interacting with a system or a product, through their 
participation in the different phases of the development 
process. Three phases have been carried out: 
1. Research Phase: user needs and main functionalities 
are extracted employing ethnographic techniques 
through interview and meeting with stakeholders, 
research on the state of the art and a market survey. 
2. Concept Validation: a confrontation with users 
(patients, relatives, caregivers) is prepared to gather 
their insights on the concepts and extract their user 
demands and needs regarding interaction. 
3. Development Phase: based on the previous point 
mockups are prepared and then validated through 
heuristic analysis by interaction experts. 
Users are involved in all the phases through: 
• Focus Group and Interviews: the goal is to gather 
information about the needs of patients related to the 
feedback strategy and contents. 
• Usability Tests: to determine the usability of one 
prototype and to find ways to improve it (“formative 
testing”). DIN EN ISO 9241 and ISO 3407 has been used 
as the foundation of the test, as it is an internationally 
accepted standard. According to it, usability is “the 
extent to which a product can be used by specified users 
to achieve specified goals with effectiveness, efficiency 
and satisfaction in a specified context of use.”  
This is how usability can be measured, according to this 
standard:  
• efficacy is the extent to which the user is able to achieve 
the respective goal(s). A common operationalisation of 
efficacy is the percentage of tasks completed 
successfully by the user.  
• efficiency is the efficacy of the user, divided by the 
amount of resources the user needs to spend in order to 
reach this efficacy. A common measure of efficiency 
would therefore be the time to complete each task.   
• satisfaction is the user’s “subjective reaction” to the 
interaction with the product (ISO 9241). According to 
[4], user satisfaction is an emotion which results from 
the user comparing his expectations of the system to his 
actual experiences with it. Satisfaction can therefore 
only be measured by asking the user about his feelings 
towards the system. 
The main results achieved for each of the phases are 
described as follows. 
 
III. RESEARCH PHASE 
STEP 1:THE PROBLEM 
One of the first actions that were undertaken from the very 
beginning was to understand objectives and scope of the 
desired system: 70-90% of diabetics have insufficient 
glycemic control (HbA1c > 6.5-7%). Major cause for 
inadequate control is a mismatch between lifestyle and 
treatment, but < 10% of type 1 diabetics are trained to adapt 
insulin doses to food/exercise and self-dosing training is not 
available for type 2 diabetics. 
In terms of costs, the International Diabetes Federation 
(IDF) estimates that the equivalent of an additional 23 million 
years of life are lost each year to the disability and to reduced 
quality of life caused by the preventable complications of 
diabetes; in Europe IDF estimates [11] that the yearly cost of 
diabetes is around 67 Million International Dollars. 
Clinicians can usually dedicate few minutes to each visit. It 
is currently difficult to predict which patient will be adherent. 
Many treatments fail because clinicians do not recognize non-
compliant patients or a need of therapy scheme change. 
Meanwhile, patients frequently disagree with their 
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physicians’ plans and this is a major cause of a lack of  
compliance [2] since patients have veto power over doctor 
recommendations. 50% of patients leave office without 
having understood what their doctors told them to do [5]. 
About 50% of diabetic patients are not compliant with 
medications [6]. 
Care of diabetes is mainly based on drug administration at 
dosages which depend on the glucose level measured at fixed 
times during the day. These discrete measurements however 
do not allow calibrating correctly the drug dosage and even 
the most recent technologies for automatic insulin level 
measurement and drug infusion do not allow an optimal 
therapy assessment, being semi-invasive devices which 
patients wear only when required. 
A team composed by industrial leaders in the field of HC 
technologies (Medtronic, others) defined, together with 
clinicians (University of Parma, Local Health Unit of 
Modena, Hospital San Carlos of Madrid, Charles University 
in Prague) and IT researchers (human computer interaction 
experts, biomedical engineers, authors of this paper), the 
open-ended approach with the aim of providing an in-depth 
study about the users in their natural environment. The result 
of this first step was the definition of SIX SEGMENTS (1. 
Changes in the environment, 2. Physical exercise, 3. Sudden 
hypoglycemic events, 4. Lack of motivation, 5. Unstable 
diabetes control, 6. Co-morbidity disease management): these 
are areas of focus representing what, according to 
ethnographic techniques, is defined as “the user natural 
environment within context of a specific process, situation, 
occasion, product and service. It’s more than just another 
qualitative study” [7]: this categorization does not center in 
patients phenotypization, but addresses some specific 
situations in which patients may develop specific needs. It 
was under this framework that the further research was 
carried out: 
STEP 2: USER NEEDS  
Insights were gathered through meetings with clinicians, 
market analysis and technology experts, reflecting the study 
of the different user requirements to address each segment in 
order to set the technological feasibility to develop a system 
that can contribute to a better control of the diabetes disease 
management. 
Not only a review of the particular user needs related to 
each segment was done, but also a general description of the 
basic features that the system could have provided for the six 
segments and that are common for all the users, 
independently of their profile. They can be summarized as: 
• Acquisition of information from glucose readings and 
to the patient’s lifestyle: food intake, drug intake, 
physical activity, etc. 
• Acquisition of information related to complications 
and co-morbidities interacting with the diabetic disease 
• Measurement of different variables related with the 
patient’s ongoing treatment evolution such as weight, 
fat %, etc. 
• Design of a decision support system to assist in the 
recommendations for patients, enhancing 
empowerment and self-assurance of diabetic patients. 
STEP 3: FOCUSED RESEARCH 
Following the directives of the user needs, a State of the 
Art analysis was also focused in the six different segments, 
doing a research on the available technology that can be used 
by the system, identifying sensors and methodologies for the 
data acquisition. 
Research was also carried out on data collection tools (for 
Indoor/Outdoor Scenarios, Fixed and Mobile, etc.). An 
investigation of the market needs was done in terms of 
innovation, support to patients and with an eye on the health 
strategies adopted by EU Member States’ National Health 
Systems. The main determinants influencing success of 
telemedicine project implementation identified were: 
 
Table 1 Factors influencing success in telemedicine projects 
Technology Acceptance Legislation 
Support to users, both 
in  implementation and 
operational phase in 
installation, 
maintenance and error 
management; 
Training in particular 
if the system has an 
high degree of 
innovation; 
Usability tailored on 
skills of specific users, 
mainly referring to 
wearable or mobile 
devices or access to 
services; 
Quality and reliability 
of materials and 
connections. 
Attitude of patient and 
towards the system; 
Evidence based 
medicine studies 
availability, with 
highest quality 
methodology 
Diffusion and 
dissemination plan 
oriented to highlight 
the main features. 
Current legislation 
does not cover all the 
aspect of telemedicine. 
Legal standardization 
is very difficult to 
achieve at an 
international level. 
Member states legal 
framework is not 
homogeneous: major 
barrier to wide-scale 
system implementations 
and increased device 
“time to market”. 
 
The final steps that led to the Concept definition were: 
• Meetings with physical activity in diabetes experts, 
diabetes psychologists and  
• Interviews with patients 
Users’ applications were defined in terms of: 
• Objectives 
• What is expected from the application 
• What is required from users 
Every module of the application was defined from both 
clinical and technical points of view. 
The main modules identified were: 
• Glycaemic Module 
• Food Intake 
• Physical Activity 
• Events Registration Module 
• Diary 
• Graphic Tools 
• Motivation and Feedback Tool 
  STEP 4: CONCEPT VALIDATION 
A confrontation with patients was prepared to gather their 
insights on the concepts and extract their user demands and 
needs regarding interaction. For this, interviews with 20 
diabetic patients (16 T1DM, 4 T2DM) were prepared and 
completed. Interview methodology and strategy adopted has 
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taken [8] and [9] as major references. The results obtained in 
these interviews were interpreted by a group of interaction 
designers to continue the process of refinement of all the 
concepts. General impressions gathered were: 
• The concepts were generally very well accepted  
• Special interest on activity reports and simulation tool 
before physical activity 
• Major concern about the interaction time with the system 
• Trust issues: most patients need to try the system 
themselves to prove it is reliable 
• Good acceptance of feedback and recommendations, 
alerts and reminders but only if they were on demand (if 
they could be switched on and off) 
• Major concern on the amount of devices to be needed 
• Some users would appreciate using their own computers 
too. 
 
DEVELOPMENT PHASE 
Based on the work carried out in the research phase, the 
concept preparation and the first confrontations with patients 
and validation of the concepts, the main target users of the 
application were defined. These descriptions are based on the 
characterizations of the primary and secondary PERSONAs: 
PERSONAs are a precise descriptive model of the user, of 
what he or she wants to accomplish and why he or she wants 
to accomplish their goals. A well developed PERSONA 
comprises information on goals, attitudes, work or activity 
flow, environment, capacities and level of competence and 
frustrations. The definition of PERSONAs led to the creation 
of scenarios, which resume a regular day in the life of the 
PERSONAs and allow identifying the real needs. Scenarios 
were first created without the existence of the system and 
later, introducing it: through this approach, it was possible to 
recognize more easily the direct benefits of the use of the 
system that could be brought to the life of users. 
As for patients, two PERSONAs were defined: 
1. Ana, T1DM young patient insulin treated; most frequent 
tasks are related to the insertion of medical and 
biographical data. The functionalities provided by the 
system resemble the actions that the patient is used to 
perform, like the paper diaries or notebooks where 
patients take note of their measurements and comments. 
“Ana patients” have a fast and easy access to the data 
insertion functionalities. Patients have access to the diary 
and graphics areas from the home screen, but graphics 
and diary will not be shown directly on the home screen. 
Data reviewing is also a voluntary action. Feedback from 
health professionals should also be present at the home 
screen of the application. As most of this feedback will 
take place in the form of messages, the user will be able 
to see how many new, unread messages there are in the 
message inbox, as well as a direct access to the agenda 
where the application will show the next appointment or 
activity scheduled. Feedback takes place in the form of 
messages that are related with the correct usage and 
insertion of the information in the system. 
2. George, T2DM aged patient not insulin treated. The 
focus should not be on data insertion, but on education, 
communication and empowerment to adopt a healthier 
lifestyle. Patients with similar characteristics to George – 
most elderly T2DM patients – will usually be not insulin 
dependent, will suffer a number of co-morbidities and 
will probably have a complex medication regime. A 
special effort should be made in providing educational 
and motivational content, aiming to empower patients to 
change their routines and to adopt a healthier lifestyle. 
The application should be placed on lifestyle 
management and on feedback from health professionals. 
Most of the interaction to be defined for the application 
for elderly patients will be mainly application-driven, 
often started by the application by prompting messages 
and reminders. 
 
IV. RESULTS 
FOCUS GROUPS 
Focus groups with 23 patients (11 T1DM and 12 T2DM) 
were done in Madrid and Parma. 
 General results and lessons learned:  
Ana: 
• The feedback messages needed to be reviewed and 
validated with patients and clinicians 
• Physically intense labor had to be incorporated 
• The dynamics of the focus had to be reviewed within 
frequent functions.  
• The diary should include suggestions and indicate critical 
messages.  
• The feedback decision support was indeed necessary, in 
order to give help when it’s needed, e.g., when travelling 
• Not all messages were to be kept stored in the system but 
only selected ones and for a selected period of time only. 
George: 
• Not all messages were to be kept stored in the system but 
only selected ones and for a selected period of time only. 
• The once proposed core-engine is indeed necessary, in 
order to provide the correct number and kind of messages 
at the correct time  
• Diary and Advisor should rather be available as dialogue 
functions, associated to certain topics: medication, food, 
exercise, etc .  
• The messages in the database needed to be reviewed. 
Some messages were changed, others were entirely taken 
out (especially those that were considered rude and not 
utile). 
Common insights: 
• The division into “Ana”- and “George”-users is 
necessary.    
• The basic structure of Ana’s PMD caters well for the 
users’ needs.  
• Providing real-time, data-based recommendations is 
wanted by all user groups.  
• The most important topics are food and exercise (both, 
T1DM and T2DM).  
Unlike other patients / elderly users, there are not any 
thoughts to reject aid-functions among diabetes patients. 
 
USABILITY TESTS 
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36 T1DM patients from Madrid, Modena and Parma were 
tested. The usability problems were reported to the 
development teams and have been addressed by them in the 
meantime. All in all, 43 different usability problems were 
identified within the tests. There were only few highly severe 
errors but a significant number of errors of medium severity, 
which needed to be addressed in order to assure a sufficient 
acceptance of the final application. The users’ satisfaction 
with the “Ana”-Application was substantially higher than a 
medium score, which is the level of quality that we expect 
from this software.  
Comments and wishes of the participants were also 
recorded. As users are neither designers nor technology 
experts, following their comments does not always lead to an 
increased usability. However, such comments should be 
checked when developing a user interface. We included these 
comments in our discussions when focusing on the 
improvement of the Ana-Application. We mention them here 
in order to give a complete picture of what was discussed, 
without putting all the details to each issue. 
 
Table 2 – comments and wishes, concerning the “Ana”-Application 
In the diary, the patient prefers most recent event at the top.
In the diary, the events should be ordered by their time of happening, not 
by the time they were entered.  
About the red marked days in the monthly, agenda, patients suggested that 
they would show: Hypo (past events), Hyper (past events), sickness (past 
events), Visit to a Physician (future events), Agenda item (e.g., date) 
Patients wished to see the reason for Hypo/hyper events 
Patient preferred a correct relation between entering manual gr and adding 
more food by arrow on the virtual plate 
"We calculate not in gr (CHO) but in "raciones" (this makes input more 
difficult and confuses in the main menu) 
Some patients did not know how to calculate CHO or did not even know 
what that is.  
The main screen should show a value that patients know: CHO in Italy, 
Raciones in Spain, … 
The participant preferred to visualize in the main screen CHO than Kcal 
It's not possible to erase old agenda items 
 
As Figure 1 shows, the users’ satisfaction with the “Ana”-
Application (calculated with the AttrakDiff questionnaire 
[12]) was substantially higher than a medium score, which is 
the level of quality that we expect from this software.  
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Figure 1 – Satisfaction with the “Ana”-Application 
 
V. CONCLUSIONS 
In this article we have described the process of defining 
patient interfaces for a complex telemedical platform system. 
We further depicted the outcomes of the different research 
steps indicating that diabetic patient vary in their specific 
needs regarding telemedical support, not only between patient 
subgroups but also intra-individually depending on the 
context and on the motivational status. 
The METABO system is complex for two reasons: not only 
is Diabetes Mellitus a disease that require the control of a 
great variety of different lifestyle aspects; METABO also 
integrates many different data sources and actors. Therefore, 
the UCD process requires a broader methodology and 
recurrent involvement of end-users. 
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